Stratification

Stratification

  1. lut 28, 2025

What Does the 'Stratification’ Mean?

Stratification in clinical research refers to the process of dividing study participants into subgroups based on specific characteristics or factors. These factors can include age, gender, disease severity, or other relevant variables that might influence the study outcomes.

The primary purpose of stratification is to ensure a balanced distribution of important variables across treatment groups. By doing so, researchers can minimize bias, increase statistical power, and improve the validity of their results when comparing different interventions or treatments.

Why Is the 'Stratification’ Important in Clinical Research?

Stratification is crucial in clinical research as it helps control for confounding variables that could skew study results. By ensuring a balanced distribution of key characteristics across treatment groups, researchers can more accurately attribute observed effects to the intervention being studied rather than to pre-existing differences between groups.

Furthermore, stratification enhances the statistical power and efficiency of clinical trials. It allows for more precise subgroup analyses, which can reveal important differences in treatment effects among specific patient populations, ultimately leading to more personalized and effective medical interventions.

Good Practices and Procedures

  1. Identify stratification factors early in the study design phase, preferably during protocol development
  2. Limit the number of stratification factors to avoid overly complex randomization and small subgroups
  3. Use dynamic allocation methods, such as minimization, for studies with multiple stratification factors
  4. Implement stratification through a validated computerized system to ensure accuracy and reduce human error
  5. Document the stratification process thoroughly in the statistical analysis plan for transparency and reproducibility

Related Terms

Resources

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…